Hui TP, Kandola A, Shen L, Lewis G, Osborn DPJ, Geddes JR, Hayes JF. A systematic review and meta‐analysis of clinical predictors of lithium response in bipolar disorder.

SummationsOur results suggest that predictors of good response are (i) mania‐depression‐interval sequence, (ii) absence of rapid cycling (iii) absence of psychotic symptoms, (iv) shorter prelithium illness duration, (v) family history of bipolar disorder and (vi) later illness onset. Additional features which may be related to response are body mass index, number of episodes before lithium treatment, number of hospitalisations before lithium and family history of lithium response.LimitationsVery few of the studies explored the possibility of interdependence or interaction between predictors.Because of the limitations of the data, particularly the limited number of RCTs, it is difficult to separate predictors of lithium response from predictors of a benign illness course.Because of the low reliability of the results and the inability to eliminate biases, any clinical conclusions relating to any single predictor should be made cautiously.

Introduction {#acps13062-sec-0008}
============

Globally, guidelines recommend lithium as first‐line maintenance treatment for bipolar disorder (BPD) [1](#acps13062-bib-0001){ref-type="ref"}, [2](#acps13062-bib-0002){ref-type="ref"}, [3](#acps13062-bib-0003){ref-type="ref"}. While lithium has a higher complete response rate than other mood stabiliser medication, only one in three patients will respond well to the drug [4](#acps13062-bib-0004){ref-type="ref"}. A number of studies have attempted to identify predictors of response from biological, genetic, clinical and psychosocial characteristics. A recent review of biomarkers to predict lithium response was somewhat discouraging [5](#acps13062-bib-0005){ref-type="ref"}. Genome‐wide association studies have developed a polygenic risk score for lithium response [6](#acps13062-bib-0006){ref-type="ref"} and large biological marker studies are just beginning [7](#acps13062-bib-0007){ref-type="ref"}. However, despite enormous potential to improve our understanding of the lithium‐responding subtype of BPD, these approaches are unlikely to be able classify responders accurately without the inclusion of additional clinical features [6](#acps13062-bib-0006){ref-type="ref"}. We identified four reviews of multiple clinical lithium response markers, with the most recent attempt to meta‐analyses original studies published in 2005 [8](#acps13062-bib-0008){ref-type="ref"}, [9](#acps13062-bib-0009){ref-type="ref"}, [10](#acps13062-bib-0010){ref-type="ref"}, [11](#acps13062-bib-0011){ref-type="ref"}. These reviews are limited in their scope as they are not systematic and fail to meet PRISMA standards [12](#acps13062-bib-0012){ref-type="ref"}. Factors associated with lithium response described in these reviews include the course of illness, family history of bipolar disorder, family history of lithium response, age at illness onset, number of bipolar hospitalisations, mania‐depression‐interval (MDI) course sequence, depression‐mania‐interval (DMI), continuous cycling (CC) (\<4 episodes per year without euthymic intervals [13](#acps13062-bib-0013){ref-type="ref"}), rapid cycling (RC) (≥4 episodes per year [13](#acps13062-bib-0013){ref-type="ref"}) and bipolar II disorder (BPD II). We also identified reviews which examined single predictors: pretreatment episode count [14](#acps13062-bib-0014){ref-type="ref"} and episode sequence [15](#acps13062-bib-0015){ref-type="ref"}. In the light of these issues, we systematically reviewed the existing literature on clinical predictors of lithium response in BPD and performed meta‐analysis where possible.

Methods {#acps13062-sec-0009}
=======

This systematic review followed the MOOSE guidelines and PRISMA statement [12](#acps13062-bib-0012){ref-type="ref"}, [16](#acps13062-bib-0016){ref-type="ref"}.

Eligibility criteria {#acps13062-sec-0010}
--------------------

We included randomised trial and observational studies, including adult participants diagnosed with BPD receiving lithium monotherapy. Studies that did not report separate analyses of patients treated with lithium were excluded. Studies examining the use of lithium for other indications (such as unipolar depression) were excluded. We considered studies to be eligible for inclusion if they reported an association between patient level factors (e.g. age at illness onset) and any definition of a lithium response (e.g. recurrence under lithium treatment).

Information sources {#acps13062-sec-0011}
-------------------

We searched EMBASE, Medline and Web of Science from inception to July 2018; the final search was performed on July 14, 2018. Additional studies were identified through screening reference lists of included studies and relevant papers. We included only English language studies in humans. Other articles relevant to this topic were searched for via Google Scholar, using reference lists of relevant studies.

Search {#acps13062-sec-0012}
------

We used the following search terms to search all trials registers and databases: \[Lithium\* OR lithium blood level OR lithium carbonate OR lithium citrate OR treatment response\* OR drug response\* OR predictor\*\] AND \[Bipolar disorder\] AND \[observational stud\* OR controlled clinical trial\* OR RCT OR randomised controlled trial\*\].

Study selection {#acps13062-sec-0013}
---------------

Eligibility screening was performed independently by three reviewers. The first author (TPH) screened the titles and abstracts of potential studies to determine inclusion, with a 20% random sample of records independently screened by two reviewers (AK and LS). Eligible studies were subsequently confirmed by the three reviewers (TPH, AK and LS) who independently checked the full text of all retrieved articles. Disagreement was resolved through discussion and consensus between TPH, AK, LS and JFH.

Data collection process {#acps13062-sec-0014}
-----------------------

One reviewer (TPH) extracted the following data from included studies and the second (LS) checked the extracted data, including author details, year of publication, types of study design, sample size, interventions investigated, comparison, outcome evaluation or definition of lithium response and key finding. Disagreements were resolved by discussion between TPH, AK, LS and JFH.

Data items {#acps13062-sec-0015}
----------

Information was extracted from each included study on: (i) characteristics of study participants (including sample size and number of lithium responders and non‐responders; (ii) intervention details (dose, duration of lithium treatment); (iii) definition of a treatment response (number of recurrence under lithium treatment, reduction in time spent in hospital under lithium treatment, reduction of episode frequency, or improvement during lithium treatment based on valid scales, such as Illness severity index (ISI) [17](#acps13062-bib-0017){ref-type="ref"}, Affective Morbidity Index (AMI) [18](#acps13062-bib-0018){ref-type="ref"} and ALDA scale [19](#acps13062-bib-0019){ref-type="ref"}); (vi) potential predictors examined; (v) summary results. Data sharing is not applicable to this article as no new data were created or analysed in this study.

Risk of bias in individual studies {#acps13062-sec-0016}
----------------------------------

Three reviewers (TPH, AK and LS) independently rated each eligible study. The quality of each individual study was evaluated using the modified Downs and Black quality assessment scale (Table [S1](#acps13062-sup-0001){ref-type="supplementary-material"}), which consists of 26 questions to evaluate both randomised and non‐randomised studies [20](#acps13062-bib-0020){ref-type="ref"}. Question 27 evaluating power was excluded as power should not be part of quality assessment as the aim of a meta‐analysis is to detect an effect from inconclusive or underpowered studies. Each criterion is worth one point, and a total score of 20 or above, between 15 and 19, and 14 or below is considered a study of good, fair and poor quality respectively. This quality assessment tool evaluates study reporting, external and internal validity including bias and confounding. Discrepancies between the two reviewers were resolved by discussion and consensus.

Synthesis of results and risk of bias across studies {#acps13062-sec-0017}
----------------------------------------------------

Meta‐analyses were performed after the four assumptions of homogeneity were assessed: (i) studies should be similar in terms of patients recruited; (ii) studies should be comparing the same intervention or exposure with similar controls, (iii) studies should be reporting the same outcomes, (iv) the effect of a predictor should ideally be in the same direction [21](#acps13062-bib-0021){ref-type="ref"}. Narrative analysis was carried out along with meta‐analysis if only some of the included studies met all of the criteria. For each meta‐analysis, where there were two or more studies using the same sample of patients, we excluded the smaller or earlier study.

Meta‐analysis using the DerSimonian and Laird random effect model was conducted for each predictor because we assumed heterogeneity existed across different studies, given the definitions of lithium response across studies were inconsistent [22](#acps13062-bib-0022){ref-type="ref"}. For binary outcomes, results of the primary studies were summarised as odds ratios (ORs). For continuous outcomes, results of the primary studies were summarised in standardised mean difference (SMD). Pooled ORs or SMDs and corresponding 95% confidence intervals were calculated if two or more studies reported the same clinical predictor.

A number of studies categorised patients with BPD as 'partial responder' in addition to 'responder' and 'non‐responder'. In order to conduct the random‐effects pairwise analysis, we combined the group 'partial responder' and 'non‐responder' and formed the group 'partial or non‐responder' to avoid chances of data contamination that might impact the results of clinical predictors of lithium responders. Heterogeneity for each predictor was assessed using forest plots and a measure of inconsistency (*I* ^2^). Publication bias was examined visually through evaluating funnel plots. Stata version 15 was used for all analyses.

Results {#acps13062-sec-0018}
=======

Studies included {#acps13062-sec-0019}
----------------

Our search resulted in 3897 unique citations. Of these, 3670 studies were excluded as the titles and abstracts were not relevant to the research topic, leaving 137 potentially eligible studies for which the full text was reviewed (Fig. [1](#acps13062-fig-0001){ref-type="fig"}). At this stage, 71 studies did not meet the inclusion criteria. An additional five studies that met the inclusion criteria were identified by checking the references of relevant papers and searching via Google Scholar. A total of 71 studies met all inclusion criteria and were included in systematic review, and 44 of these provided data which could be meta‐analysed. These studies are described in Table [1](#acps13062-tbl-0001){ref-type="table"}. Studies were excluded from the meta‐analysis if the population overlapped with another included study population or if it was not possible to calculate the OR or SMD. This meant two large studies using Danish population registers could not be included [23](#acps13062-bib-0023){ref-type="ref"}, [24](#acps13062-bib-0024){ref-type="ref"}.

![PRISMA flow diagram.](ACPS-140-94-g001){#acps13062-fig-0001}

###### 

Characterisation of selected studies (*n* = 71) and the clinical predictors of lithium response

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Author**                                                       **Year**   ***n***   **Lithium level & treatment duration**                                      **Clinical Predictors (** [\*](#acps13062-note-2000){ref-type="fn"} **included in meta‐analysis)**                  **Definition of treatment response**                                               **Key Findings as reported in published study**                                                                                                                                                                                                                                                                                                               **Study quality**
  ---------------------------------------------------------------- ---------- --------- --------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------
  Aronoff & Ebstein [55](#acps13062-bib-0055){ref-type="ref"}      1970       18        Level: na\                                                                  Family history of affective disorder[\*](#acps13062-note-2000){ref-type="fn"}                                       Recurrence under lithium                                                           Five of seven patients with good response had a family history of affective disorder, compared to one of five in suboptimal responders (p‐value na)                                                                                                                                                                                                           POOR
                                                                                        Duration: 3 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Mendlewicz et al. [56](#acps13062-bib-0056){ref-type="ref"}      1973       43        Level: 0.8--1.3 mmol/l                                                      Family history of affective illness\                                                                                Time to recurrence                                                                 Fifteen out of 24 responders to lithium had a positive family history of BPD, while only two out of the 12 non‐responders had a positive family history (0.02 \< *P *\< 0.05).\                                                                                                                                                                                
                                                                                                                                                                    Family history of BPD                                                                                                                                                                                  Eighteen lithium responders had a positive family history of unipolar depression, compared with nine patients in the non‐responder group (p‐value NS)                                                                                                                                                                                                         

  Prien et al. [57](#acps13062-bib-0057){ref-type="ref"}           1974       205       Level: 0.7 (mean) mmol/l,\                                                  Number of episodes prior lithium treatment\                                                                         Reduction of episode frequency                                                     55% patients in the low‐frequency group and 65% patients in the no‐episode group were lithium responders compared to 0% patients in the high‐frequency group (*P* \< 0.01).\                                                                                                                                                                                  FAIR
                                                                                        Duration: 2 years                                                           Family history of BPD[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                         The group with a family history of BPD had a higher proportion of responders (88%), than the group with no family history (49%), (*P*‐value NS)                                                                                                                                                                                                               

  Dunner & Fieve [25](#acps13062-bib-0025){ref-type="ref"}         1974       55        Level: 0.7--1.2 mmol/l\                                                     Age at illness onset\                                                                                               Recurrence of mood episodes                                                        Age at illness onset, age at study start, sex and type of BPD were not related to lithium response (*P*‐value na)                                                                                                                                                                                                                                             FAIR
                                                                                        Duration: ≥6 months                                                         Sex\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    Age at study start\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Subtype of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                    RC[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Dunner et al. [58](#acps13062-bib-0058){ref-type="ref"}          1976       96        Level: na\                                                                  Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Time to recurrence                                                                 Sex, number of previous episodes and age at first hospitalisation were associated with lithium response (*P* \< 0.01)\                                                                                                                                                                                                                                        POOR
                                                                                        Duration: na                                                                Number of episodes prior to lithium treatment\                                                                                                                                                         Nature of index episode, age at illness onset, age at first treatment and family history were not associated with lithium response (p‐value NS)                                                                                                                                                                                                               
                                                                                                                                                                    Index episode polarity[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                    cycling index episode\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                    Age at first treatment\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                    Age at illness onset\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Age at first hospitalisation\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    Family history of affective illness[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    Family history of BPD[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Ananth et al. [59](#acps13062-bib-0059){ref-type="ref"}          1979       59        Level: ≤0.8 mmol/l\                                                         Psychotic symptoms[\*](#acps13062-note-2000){ref-type="fn"}\                                                        Recurrence under lithium or need of co‐medication                                  Non‐responders (61%) displayed more psychotic symptoms during the duration of their illness (*P* \< 0.05)\                                                                                                                                                                                                                                                    POOR
                                                                                        Duration: 2 years                                                           Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                          Sex, type of index episode and cyclothymic personality were not a lithium response predictor (*P*‐value NS)                                                                                                                                                                                                                                                   
                                                                                                                                                                    Index episode polarity[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                    Cyclothymic personality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Rosenthal et al. [60](#acps13062-bib-0060){ref-type="ref"}       1979       66        Level: 0.5 to 1.2 mmol/l\                                                   Psychotic symptoms                                                                                                  Recurrence under lithium                                                           Presentation of psychotic symptoms during mania appeared to be associated with good lithium maintenance response (*P* \< 0.05)                                                                                                                                                                                                                                FAIR
                                                                                        Duration: 9--15 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Kukopulos et al. [61](#acps13062-bib-0061){ref-type="ref"}       1980       294       Level: na\                                                                  MDI/DMI sequence[\*](#acps13062-note-2000){ref-type="fn"}\                                                          No recurrences for \>1 year                                                        MDI vs DMI odds ratio = 3.3 (*P* = 0.0002)                                                                                                                                                                                                                                                                                                                    POOR
                                                                                        Duration: na                                                                IRR[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    CC[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Sarantidis & Waters [62](#acps13062-bib-0062){ref-type="ref"}    1981       46        Level: na\                                                                  Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                      Reduction in time spent in hospital under lithium treatment.                       Age at illness onset, episode frequency, family history and sex were not associated with lithium response (*P*‐value na)                                                                                                                                                                                                                                      POOR
                                                                                        Duration: ≥2 years                                                          Number of episodes/year prior to lithium treatment\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Family history of affective disorder[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Sex[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Abou‐Saleh [40](#acps13062-bib-0040){ref-type="ref"}             1983       53        Level: 0.6 to 1.3 mmol/l\                                                   Personality traits: extrovert; neuroticism, psychoticism; lie; dominance; intropunitiveness; extrapunitiveness      Recurrence under lithium                                                           Deviant personalities were associated with poor lithium response. 24% responders were 'deviant personalities' and 57% non‐responders showed this abnormality (*P* \< 0.05)\                                                                                                                                                                                   POOR
                                                                                        Duration: ≥2 years                                                                                                                                                                                                                                                                 The average score of neuroticism was significantly lower for lithium responders compared to non‐responders (*P* \< 0.01)                                                                                                                                                                                                                                      

  Yang [63](#acps13062-bib-0063){ref-type="ref"}                   1985       101       Level: 0.5--1.0 mmol/l\                                                     Age at illness onset\                                                                                               Reduction in episode frequency/admission                                           Age at illness onset and number of episodes prior lithium were not associated with lithium response (*P*‐value na)                                                                                                                                                                                                                                            POOR
                                                                                        Duration:\>2 years                                                          Number of episodes prior lithium treatment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  O\'Connell et al. [41](#acps13062-bib-0041){ref-type="ref"}      1985       60        Level: 0.5--1.2 mmol/l\                                                     Social support                                                                                                      Recurrence under lithium                                                           High social support was associated with better functioning and fewer recurrent episodes (*P* \< 0.05)                                                                                                                                                                                                                                                         POOR
                                                                                        Duration: 92.4 months (mean)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Abou‐Saleh & Coppen [64](#acps13062-bib-0064){ref-type="ref"}    1986       31        Level: 0.5--0.7 mmol/l\                                                     Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Average morbidity index under lithium                                              Good responders had fewer episodes prior to lithium compared to fair to poor responders (*P* \< 0.04)\                                                                                                                                                                                                                                                        FAIR
                                                                                        Duration: 3 years                                                           Number of previous episodes prior lithium treatment[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                          Patients with a family history of BPD had significantly higher lithium response than those with no family history (*P* \< 0.05)                                                                                                                                                                                                                               
                                                                                                                                                                    Family history of BPD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Bouman et al. [65](#acps13062-bib-0065){ref-type="ref"}          1986       104       Level: na\                                                                  Number of previous episodes prior to lithium treatment                                                              Recurrence during lithium treatment                                                16% of BPD patients who were commenced on lithium treatment during their index episode relapsed compared to 32% BPD patients who had multiple episodes prior to lithium treatment (*P*‐value na)                                                                                                                                                              FAIR
                                                                                        Duration: 10 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Mander [42](#acps13062-bib-0042){ref-type="ref"}                 1986       98        Level: \>0.4 mmol/l\                                                        Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                        Recurrence during lithium treatment                                                No significant differences between responder and non‐responders by any potential predictors                                                                                                                                                                                                                                                                   POOR
                                                                                        Duration: 3−6 months                                                        MMRS (modified manic rating scale, severity rating)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    Duration of illness\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    Social class\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    Received treatment for previous episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                    Extrovert/cyclothymic personality; Family history of affective disorder[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                    Alcohol and drug use[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Depressive symptoms\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    Compulsory admission                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Goodnick et al. [66](#acps13062-bib-0066){ref-type="ref"}        1987       91        Level: 0.71 (±0.14) mmol/l\                                                 Sex\                                                                                                                Recurrence during lithium treatment                                                No significant differences between responder and non‐responders by any potential predictors                                                                                                                                                                                                                                                                    
                                                                                        Duration: 44.6 (±20.4) months                                               Age at study start\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Subtype of BPD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Age at illness onset\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    RC\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Family history of any affective disorder\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                    Family history of BPD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Grof et al. [67](#acps13062-bib-0067){ref-type="ref"}            1987       50        Level: 0.7 mol/l (mean)\                                                    MDI/DMI sequence[\*](#acps13062-note-2000){ref-type="fn"}\                                                          Reduction of episode frequency                                                     94% of MDI patients were lithium responders\                                                                                                                                                                                                                                                                                                                  POOR
                                                                                        Duration: ≥2 years                                                          IRR[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                          55% of DMI patients were lithium responders\                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    CC[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                            85% of IRR patients were lithium responders\                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                           33% of CC patients were lithium responder                                                                                                                                                                                                                                                                                                                     

  Haag et al. [68](#acps13062-bib-0068){ref-type="ref"}            1987       93        Level: na\                                                                  MDI/DMI sequence[\*](#acps13062-note-2000){ref-type="fn"}\                                                          Reduction of number of hospitalisations per year                                   45% MDI patients were lithium responders\                                                                                                                                                                                                                                                                                                                     POOR
                                                                                        Duration: na                                                                IRR[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                          10% DMI patients were lithium responders\                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                    CC[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                            3% IRR patients were lithium responders\                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                           0% CC patients were lithium responders                                                                                                                                                                                                                                                                                                                        

  Lusznat et al. [69](#acps13062-bib-0069){ref-type="ref"}         1988       54        Level: 0.6--4 mmol/l\                                                       Euphoric mood prior treatment\                                                                                      Recurrence during lithium treatment                                                Euphoric mood at admission was associated with poor lithium response but good carbamazepine response (p‐value na)\                                                                                                                                                                                                                                            GOOD
                                                                                        Duration: 6 weeks: double blind                                             Sex[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                           83% of poor lithium responders were male, compare to 20% of good responders (p‐value na)                                                                                                                                                                                                                                                                      

  Faedda et al. [70](#acps13062-bib-0070){ref-type="ref"}          1989       40        Level: na\                                                                  MDI/DMI sequence[\*](#acps13062-note-2000){ref-type="fn"}\                                                          No recurrences for \>1 year                                                        MDI vs DMI odds ratio 2.7 (*P* = 0.31)                                                                                                                                                                                                                                                                                                                        POOR
                                                                                        Duration: na                                                                IRR[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    CC[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Maj et al. [71](#acps13062-bib-0071){ref-type="ref"}             1989       118       Level: 0.5--1.0 mmol/l\                                                     MDI/DMI sequence[\*](#acps13062-note-2000){ref-type="fn"}\                                                          Average reduction in morbidity                                                     MDI and IRR groups had a significant reduction of number of episodes after receiving lithium treatment compared to DMI and CC groups (*P* \< 0.001)\                                                                                                                                                                                                          FAIR
                                                                                        Duration: na                                                                IRR[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                          MDI and IRR groups had a significant reduction of total morbidity after receiving lithium treatment compared to DMI and CC groups (*P* \< 0.001)                                                                                                                                                                                                              
                                                                                                                                                                    CC[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Miller et al. [72](#acps13062-bib-0072){ref-type="ref"}          1991       53        Level: na\                                                                  Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Global Assessment of Functioning                                                   No difference between responders and non‐responders by included predictors                                                                                                                                                                                                                                                                                     
                                                                                        Duration: na                                                                Age at study start\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Number of hospitalisations prior to lithium[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Psychotic symptoms\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Specific mood symptoms: elation, grandiosity, paranoia, agitation,irritability, aggressiveness                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  O\'Connell et al. [36](#acps13062-bib-0036){ref-type="ref"}      1991       248       Level: 0.5--1.0 mmol/l\                                                     Number of hospitalisations prior to lithium[\*](#acps13062-note-2000){ref-type="fn"}\                               Global Assessment Scale score under lithium                                        More frequent hospitalisations, lower social class and less social support was significantly associated with poorer outcome (*P* \< 0.0001)\                                                                                                                                                                                                                  FAIR
                                                                                        Duration: 8 years (±5.6)                                                    Social support\                                                                                                                                                                                        Patients whose families showed high expressed emotion were over‐represented in the poorer outcome groups (*P* = 0.004) as were those whose families had a negative affective style (*P* \< 0.0001)                                                                                                                                                            
                                                                                                                                                                    Social class\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    Expressed family negative affective style\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                    Sex                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Okuma [30](#acps13062-bib-0030){ref-type="ref"}                  1993       108       Level: n/a\                                                                 Age at illness onset\                                                                                               Time ill during lithium treatment                                                  Age at illness onset, presentation of atypical symptomatology and types of BPD were not associated with response (*P*‐value NS)\                                                                                                                                                                                                                              POOR
                                                                                        Duration: ≥2 years                                                          RC[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                           RC was associated with a poor response (*P* \< 0.01)\                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    CC[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                           Predominant mania over depression was associated with good lithium response (p‐value NS)                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Predominant polarity[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Type of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Presentation of atypical symptomatology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Gasperini et al. [26](#acps13062-bib-0026){ref-type="ref"}       1993       213       Level: 0.5--0.9 mmol/l\                                                     Age at illness onset\                                                                                               Episode frequency during lithium treatment                                         Earlier onset of illness was associated with poor lithium response and higher recurrence (*P* \< 0.0001)\                                                                                                                                                                                                                                                     FAIR
                                                                                        Duration: na                                                                Duration of illness\                                                                                                                                                                                   Longer duration of illness was associated with poor lithium response and higher recurrence (*P* \< 0.02). Greater age receiving lithium treatment was associated with poor lithium response and higher recurrence (*P* \< 0.04)\                                                                                                                              
                                                                                                                                                                    Age at study start\                                                                                                                                                                                    Both manic and depressive index episodes were not associated with lithium response (*P*‐value NS)                                                                                                                                                                                                                                                             
                                                                                                                                                                    Index episode polarity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Grof et al. [73](#acps13062-bib-0073){ref-type="ref"}            1994       380       Level: ≥0.7 mmol/l\                                                         Family history of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                     Recurrence during lithium treatment                                                A positive family history of BPD was associated with good lithium treatment response (*P*‐value na)\                                                                                                                                                                                                                                                          FAIR
                                                                                        Duration: 3--20 years                                                       Family history of any affective disorder[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                      BPD was more common in first‐degree relatives of patients who responded to lithium compared to those who did not respond (*P*‐value na)                                                                                                                                                                                                                       

  Maj et al. [74](#acps13062-bib-0074){ref-type="ref"}             1996       63        Level: 0.62 mmol/l (median)\                                                Number of episodes before lithium treatment\                                                                        Recurrence during lithium treatment                                                Late non‐responders had more episodes of prior lithium treatment compared to stable responders (*P* \< 0.05)\                                                                                                                                                                                                                                                 FAIR
                                                                                        Duration: 5 years                                                           Number of previous hospitalisations Age at study start\                                                                                                                                                Late non‐responders had more previous hospitalisations prior lithium treatment compared to stable responders (*P* \< 0.01)\                                                                                                                                                                                                                                   
                                                                                                                                                                    Prelithium illness duration\                                                                                                                                                                           Late non‐responders had an older mean age at receiving lithium treatment compared to stable responders (*P* \< 0.05)\                                                                                                                                                                                                                                         
                                                                                                                                                                    Sex\                                                                                                                                                                                                   Late non‐responders had a longer prelithium illness duration compared to stable responders (*P* \< 0.02)\                                                                                                                                                                                                                                                     
                                                                                                                                                                    Age at first psychiatric contact\                                                                                                                                                                      Sex; age at first psychiatric contact; number of affective episodes before intake; manic episodes before intake; total morbidity in the 2 years preceding intake; and family history of BPD were not predictors of lithium response (*P*‐value NS)                                                                                                            
                                                                                                                                                                    Number of manic episodes before intake; Total morbidity in the 2 years preceding intake\                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                    Family history of BPD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Denicoff et al. [75](#acps13062-bib-0075){ref-type="ref"}        1997       42        Level: 0.5--1.2 mmol/l\                                                     Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                        Morbidity during lithium treatment                                                 Younger age at the time of study entry (*P* \< 0.05), having a first treatment by age 20 or earlier (*P* \< 0.01), short prelithium illness duration (*P* \< 0.05), fewer hospitalisations (*P* \< 0.05), and manifested a depressive index episode than manic index episode (*P* = 0.05) were associated with positive response to lithium                   FAIR
                                                                                        Duration: 2 years                                                           Age of first treatment\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                    Prelithium illness duration[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Number of hospitalisations prior to lithium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Depressive index episode                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Engstrom et al. [76](#acps13062-bib-0076){ref-type="ref"}        1997       98        Level: \>0.4 mmol/l\                                                        Family history of any affective disorder\                                                                           Frequency of episodes per year                                                     More episodes per year during lithium treatment were found in patients with a family history of first‐ or second‐degree relative with any affective disorder (*P* = 0.0119), and first‐ or second‐degree relative with BPD (*P* = 0.0012), when compared to non‐familial patients\                                                                             
                                                                                        Duration: 10.0--13.0 years                                                  Family history of unipolar depression\                                                                                                                                                                 88% of non‐familial patients had a reduction in episodes during lithium treatment, compared to 77% with a family history of any affective disorder, 84% with a family history of unipolar depression and 68% with a family history of BPD                                                                                                                     
                                                                                                                                                                    Family history of BPD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Greil et al. [77](#acps13062-bib-0077){ref-type="ref"}           1998       86        Level: 0.61 (±0.12) mmol/l\                                                 Classical features: without mood‐incongruent delusions, without comorbidity, and without mixed state                Time to hospitalisation                                                            For the classical group (*N* = 67), lithium (*N* = 35) proved to be highly superior to carbamazepine in preventing hospitalisations (*P* = 0.005) but not for the non‐classical group (*P* = 0.075)                                                                                                                                                            
                                                                                        Duration: 30 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Kusalic & Engelsmann [44](#acps13062-bib-0044){ref-type="ref"}   1998       29        Level: 0.80--1.30 mmol/l\                                                   Age at study start\                                                                                                 Recurrence during lithium treatment:                                               Responders had an older mean age, longer duration of illness and presentation of family history of BPD compared to non‐responders (*P*‐value na)                                                                                                                                                                                                              FAIR
                                                                                        Duration: 2 years                                                           Prelithium illness duration\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Family history of BPD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Maj et al. [37](#acps13062-bib-0037){ref-type="ref"}             1998       247       Level: 0.64 (±0.09) mmol/l\                                                 Number of hospitalisations prior to lithium[\*](#acps13062-note-2000){ref-type="fn"}\                               Number of recurrences during lithium treatment                                     Patients with fewer hospitalisations (*P* \< 0.0001), fewer episodes before lithium treatment (*P* \< 0.0001) and patients without a RC pattern (*P* \< 0.00001) had better lithium response\                                                                                                                                                                 FAIR
                                                                                        Duration: 5 years                                                           Number of episodes prior lithium treatment[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                   Age, age of first psychiatric contact, sex, DMI pattern, family history of BPD and psychotic features in index episode were not associated with lithium response (*P*‐value NS)                                                                                                                                                                               
                                                                                                                                                                    Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Sex\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    MDI/DMI sequence\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                    RC[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Family history of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Psychotic symptoms[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Tondo et al. [38](#acps13062-bib-0038){ref-type="ref"}           1998       317       Level: na\                                                                  Prelithium illness duration[\*](#acps13062-note-2000){ref-type="fn"}\                                               Time ill during lithium treatment                                                  Prelithium illness duration was strongly negatively associated with clinical improvement (*P* \< 0.0001)\                                                                                                                                                                                                                                                     FAIR
                                                                                        Duration: 6.35 years                                                        Type of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                  The proportion of lithium treatment‐responsive patient was significantly greater among BPD II subjects (65.1%) than BPD I subjects (51.1%) (*P* = 0.01). Other predictors were NS                                                                                                                                                                             
                                                                                                                                                                    Sex\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    Family history of affective disorder\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Education\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                    Marital status\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Employment status\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                    Age at onset\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    RC\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Number of episodes prior to lithium                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Franchini et al. [78](#acps13062-bib-0078){ref-type="ref"}       1999       179       Level: 0.5--0.9 mmol/l\                                                     Prelithium illness duration                                                                                         Recurrence during lithium treatment                                                Beginning lithium treatment earlier predicted better outcome than beginning lithium treatment later (*P* \< 0.00001)                                                                                                                                                                                                                                          FAIR
                                                                                        Duration: 48 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Kulhara et al. [45](#acps13062-bib-0045){ref-type="ref"}         1999       118       Level: 0.4--1.2 mmol/l\                                                     Number of depressive episodes prior to lithium treatment\                                                           Reduction in episode frequency                                                     Good responders had fewer depressive episodes prior lithium treatment (*P* \< 0.05) and fewer of life events (*P* \< 0.05) compared to partial/poor responders\                                                                                                                                                                                               FAIR
                                                                                        duration: 11 years                                                          Number of life events\                                                                                                                                                                                 Good responders had lower total stress score compared to partial/poor responders (*P* \< 0.05)\                                                                                                                                                                                                                                                               
                                                                                                                                                                    Total stress score\                                                                                                                                                                                    Good responders had higher social support compared to partial/poor responders (*P* \< 0.05)\                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Social support score\                                                                                                                                                                                  Illness duration prior lithium treatment; number of episodes prior lithium; numbers of manic episodes prior lithium; number of hospitalisation prior to lithium were not predictors of lithium response (*P*‐value NS)                                                                                                                                        
                                                                                                                                                                    Prelithium illness duration[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Number of episodes prior to lithium treatment[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                    Number of manic episodes prior lithium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                    Number of hospitalisations prior to lithium[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Polarity of index episode[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Predominant polarity[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Yazici et al. [33](#acps13062-bib-0033){ref-type="ref"}          1999       141       Level: 0.75 (±0.08)\                                                        Age at illness onset\                                                                                               Affective morbidity index during lithium treatment                                 Greater age at disease onset (*P* \< 0.002), mild and moderate episode severity (*P* \< 0.0001), higher number of episodes prior lithium treatment (*P* \< 0.00001), fewer hospitalisations prior lithium treatment (*P* = 0.007), BPD II (*P*‐value na) and low ratio of psychotic episodes (*P* \< 0.00001) were associated with better lithium response\   FAIR
                                                                                        Duration: ≥3 years                                                          Psychotic symptoms\                                                                                                                                                                                    Psychotic symptom (*P* \< 0.00002) and mania predominance over depression (*P* \< 0.00001) were associated with poor lithium response\                                                                                                                                                                                                                        
                                                                                                                                                                    Episode severity\                                                                                                                                                                                      RC, CC, and family history of affective disorder and BPD were not predictors of lithium response (*P*‐value NS)                                                                                                                                                                                                                                               
                                                                                                                                                                    Number of episodes prior to lithium Predominant polarity\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                    Number of hospitalisations prior lithium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                    Type of BPD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Ratio of psychotic episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    RC[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    CC[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Family history of BPD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                    Family history of any affective disorder                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Baldessarini et al. [79](#acps13062-bib-0079){ref-type="ref"}    2000       360       Level: 0.61 (±0.14) mmol/l\                                                 RC[\*](#acps13062-note-2000){ref-type="fn"}                                                                         Recurrence during lithium treatment                                                Patients with RC were 13.7% less likely to be fully protected from all recurrences during lithium maintenance (*P* \< 0.04)                                                                                                                                                                                                                                   FAIR
                                                                                        Duration: 13.3 (±9.9) years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Coryell et al. [32](#acps13062-bib-0032){ref-type="ref"}         2000       186       Level: 0.72 mmol/l\                                                         Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                      Total morbidity score                                                              Greater age at illness onset was associated with better lithium response (*P* = 0.0023)\                                                                                                                                                                                                                                                                      FAIR
                                                                                        Duration: ≥26 weeks                                                         Types of BPD\                                                                                                                                                                                          BPD I was associated with better lithium response compared to BPD II (*P* = 0.018)\                                                                                                                                                                                                                                                                           
                                                                                                                                                                    Polarity of index episode[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                    Pure mania index episode was associated with better lithium response (*P* = 0.003)\                                                                                                                                                                                                                                                                           
                                                                                                                                                                    Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                           Pure depression index episode (*P* = 0.048) and cycling were associated with poor lithium response (*P* = 0.020)\                                                                                                                                                                                                                                             
                                                                                                                                                                    Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                          Age, sex, alcohol and drug use were not predictors (*P*‐value NS)                                                                                                                                                                                                                                                                                             
                                                                                                                                                                    Alcohol and drug use[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Schurhoff et al. [31](#acps13062-bib-0031){ref-type="ref"}       2000       97        Level: n/a\                                                                 Age at illness onset                                                                                                Recurrence during lithium treatment                                                64% of late onset (\>40 years) patients responded to lithium compared to 43.3% of early onset (\<18 years) patients (*P* = 0.04)                                                                                                                                                                                                                              FAIR
                                                                                        Duration: ≥1 year                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Serretti et al. [27](#acps13062-bib-0027){ref-type="ref"}        2000       61        Level: 0.4--0.7 mmol/l\                                                     Prelithium illness duration\                                                                                        Recurrence during lithium treatment                                                Correlation between clinical variables and lithium response:\                                                                                                                                                                                                                                                                                                 FAIR
                                                                                        Duration: 53 months                                                         Age at study start\                                                                                                                                                                                    Prelithium illness duration: *r* = −0.49 (*P* \< 0.001)\                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Age at illness onset\                                                                                                                                                                                  Age at study start: *r* = −0.13 (*P* = 0.312)\                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Duration of illness\                                                                                                                                                                                   Age at onset: *r* = 0.15 (*P* = 0.222)\                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Duration of lithium treatment                                                                                                                                                                          Duration of illness: *r* = −0.34 (*P* = 0.007)\                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                           Duration of lithium treatment *r* = 0.31 (*P* = 0.015)                                                                                                                                                                                                                                                                                                        

  Swann et al. [80](#acps13062-bib-0080){ref-type="ref"}           2000       35        Level: na\                                                                  Number of episodes                                                                                                  Change in Schedule for Affective Disorders and Schizophrenia mania rating scores   Fewer manic episodes associated with better response (*P* = 0.01), no association with depressive episodes (*P* = 0.1)                                                                                                                                                                                                                                        GOOD
                                                                                        Duration: 21 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Tondo et al. [35](#acps13062-bib-0035){ref-type="ref"}           2001       360       Level: 0.61 (±0.14) mmol/l\                                                 Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                      Time ill during lithium treatment                                                  Greater age at disease onset was associated with better lithium response (*P* = 0.005)\                                                                                                                                                                                                                                                                       FAIR
                                                                                        Duration: 6 (±5) years                                                      Length of euthymic interval\                                                                                                                                                                           Short interval between first and second episode was associated with better lithium response (*P* = 0.002)\                                                                                                                                                                                                                                                    
                                                                                                                                                                    Number of episodes prior to lithium\                                                                                                                                                                   Higher number of episodes per year was associated with better lithium response (*P* = 0.006)\                                                                                                                                                                                                                                                                 
                                                                                                                                                                    Prelithium illness duration[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                   Shorter prelithium illness duration was associated with better lithium response (*P* = 0.021)                                                                                                                                                                                                                                                                 

  Viguera et al. [81](#acps13062-bib-0081){ref-type="ref"}         2001       360       Not reported but likely same as [35](#acps13062-bib-0035){ref-type="ref"}   Sex                                                                                                                 Time ill during lithium treatment                                                  No difference between sexes with respect to time ill.\                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                           Time to relapse longer in women (*P* = 0.004)                                                                                                                                                                                                                                                                                                                 

  Grof et al. [19](#acps13062-bib-0019){ref-type="ref"}            2002       64        Level: n/a\                                                                 Family history of lithium response[\*](#acps13062-note-2000){ref-type="fn"}                                         Alda treatment response scale                                                      67% of relatives of lithium responsive patients responded to lithium compared to 35% of the control group (*P* = 0.014)                                                                                                                                                                                                                                       FAIR
                                                                                        Duration: ≥1 year                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Swann et al. [82](#acps13062-bib-0082){ref-type="ref"}           2002       28        Level: na\                                                                  Psychotic symptoms\                                                                                                 \>50% improvement on Manic Syndrome Score                                          Individuals with psychotic symptoms and classical presentations responded equally well to lithium or valproate                                                                                                                                                                                                                                                 
                                                                                        Duration: na                                                                Classic presentation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Hartong et al. [83](#acps13062-bib-0083){ref-type="ref"}         2003       44        Level: 0.75 mmol/l\                                                         Polarity of index episode\                                                                                          Recurrence during lithium treatment                                                Lithium was more effective than carbamazepine in patients with a (hypo)manic index episode, (*P* \< 0.01)\                                                                                                                                                                                                                                                    GOOD
                                                                                        Duration: 2 years                                                           Type of BPD                                                                                                                                                                                            Lithium was more effective than carbamazepine in patients with BPD II (*P* \< 0.05)                                                                                                                                                                                                                                                                           

  Passmore et al. [84](#acps13062-bib-0084){ref-type="ref"}        2003       164       Level: na\                                                                  Pretreatment episodic illness course\                                                                               Recurrence of mood episode                                                         Pretreatment episodic illness course was associated with good lithium response (*P* \< 0.001)\                                                                                                                                                                                                                                                                FAIR
                                                                                        Duration: na                                                                Family history of BPD                                                                                                                                                                                  16.6% of first‐degree relatives of lithium responders responded to lithium compared with 2.5% of such relatives of patients who responded to lamotrigine (*P* = 0.05)                                                                                                                                                                                         

  Washizuka et al. [85](#acps13062-bib-0085){ref-type="ref"}       2003       54        Level: 0.3--1.0 mmol/l\                                                     Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Recurrence during lithium treatment                                                Sex (*P* \< 0.01), age at illness onset (*P* = 0.04) and RC (*P* = 0.04) predict response. All other covariates NS                                                                                                                                                                                                                                             
                                                                                        Duration: 4.4 (±5.6) years                                                  Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Types of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                    Psychotic symptoms[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    RC[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Family history of any affective disorder[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Bremer et al. [86](#acps13062-bib-0086){ref-type="ref"}          2007       184       Level: na\                                                                  PTSD comorbidity                                                                                                    Reduction in symptoms                                                              People without PTSD had an improved lithium response rate compared with people with PTSD (*P* = 0.029)                                                                                                                                                                                                                                                        POOR
                                                                                        Duration: na                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Duffy et al. [87](#acps13062-bib-0087){ref-type="ref"}           2007       15        Level: ≥0.7 mmol/l\                                                         Family history of lithium response[\*](#acps13062-note-2000){ref-type="fn"}\                                        Alda treatment response scale                                                      All patients who responded to lithium had lithium responsive parents (*P* = 0.001)\                                                                                                                                                                                                                                                                           FAIR
                                                                                        Duration: ≥1 year                                                           Pretreatment episodic illness course                                                                                                                                                                   90% patients with episodic BPD responded better to lithium, and all patients with chronic BPD responded better to other mood stabilisers (*P* = 0.001)                                                                                                                                                                                                        

  Garnham et al. [4](#acps13062-bib-0004){ref-type="ref"}          2007       78        Level: na\                                                                  Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                      Alda treatment response scale                                                      The full responders had earlier onset than non‐responders (*P* = 0.03)\                                                                                                                                                                                                                                                                                       FAIR
                                                                                        Duration: ≥6 months                                                         Type of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                  Full response to lithium was better in bipolar II disorder (*P* = 0.009)\                                                                                                                                                                                                                                                                                     
                                                                                                                                                                    Pretreatment episodic illness course                                                                                                                                                                   Full response to lithium was better in those with an episodic course of illness prior to treatment (*P* = 0.004)                                                                                                                                                                                                                                              

  Rybakowski et al. [39](#acps13062-bib-0039){ref-type="ref"}      2007       111       Level: n/a\                                                                 Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                      Reduction in number of episodes                                                    Age at illness onset, age at study start, prelithium illness duration, duration of lithium treatment and number of affective episodes before lithium treatment were not associated with lithium response (*P*‐values na)                                                                                                                                      POOR
                                                                                        Duration: ≥5 years                                                          Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Prelithium illness duration[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Number of episodes prior to lithium treatment[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                    Duration of lithium treatment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Berghofer et al. [88](#acps13062-bib-0088){ref-type="ref"}       2008       242       Level: ≥0.5 mmol/l\                                                         Atypical symptoms                                                                                                   Total morbidity index (MI), depressive MI, manic MI                                Atypical symptoms of BPD were not associated with lithium response (*P* = 0.472)                                                                                                                                                                                                                                                                              FAIR
                                                                                        Duration: 10 (±6.4) years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Masui et al. [34](#acps13062-bib-0034){ref-type="ref"}           2008       161       Level: 0.4--1.2 mmol/l\                                                     Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Recurrence under lithium                                                           Greater age at disease onset is associated with better lithium response (*P* \< 0.01)\                                                                                                                                                                                                                                                                        POOR
                                                                                        Duration: ≥1 year                                                           Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                         18% BPD II patients were responders, compared to 82% of BPD II non‐responders. 34.9% BPD I patients were responders, and 65.1% BPD I non‐responders. (*P* \< 0.05). sex (*P*‐value NS)                                                                                                                                                                        
                                                                                                                                                                    Type of BPD[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Backlund et al. [28](#acps13062-bib-0028){ref-type="ref"}        2009       100       Level: 0.5 −0.9 mmol/l\                                                     Age at illness onset\                                                                                               Number of mood episodes during lithium treatment                                   The absence of mixed episodes, rapid cycling, comorbidity or onset of illness at 20 years of age or later predicted a good response to lithium (*P*‐value na). Onset of illness after 20: RR 3.4 (*P* = 0.027)\                                                                                                                                               POOR
                                                                                        Duration: 9.7 (±5.8) years                                                  RC\                                                                                                                                                                                                    No comorbidity: RR 3.3 (*P* = 0.039)\                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Mixed index episode\                                                                                                                                                                                   No mixed episodes before lithium: RR 3.5 (*P* = 0.025)\                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Comorbidity                                                                                                                                                                                            No periods of rapid cycling before lithium: RR 7.3 (*P* = 0.025)\                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                           High burden of mania before lithium: RR1.0 (*P* = 0.99)\                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                           High burden of depression before lithium: RR 0.8 (*P* = 0.72)                                                                                                                                                                                                                                                                                                 

  Calkin et al. [48](#acps13062-bib-0048){ref-type="ref"}          2009       159       Level: na\                                                                  Body mass index[\*](#acps13062-note-2000){ref-type="fn"}                                                            Alda treatment response scale                                                      Mean body mass index: complete responders \< partial \< non‐responders (*P* = 0.01)                                                                                                                                                                                                                                                                            
                                                                                        Duration: na                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Pfennig et al. [89](#acps13062-bib-0089){ref-type="ref"}         2010       336       Level: na\                                                                  Interepisode residual symptoms\                                                                                     Recurrence under lithium                                                           Recurrence rates increased in patients with interepisode residual symptoms (HR 1.45, 95% CI 1.15--1.83), mood‐incongruent psychotic features (HR 1.40, 95% CI 1.11--1.77) and RC (HR 1.86, 95% CI 1.11--3.14) and reduced in patients with family history (HR 0.67, 95% CI 0.49--0.92)                                                                         
                                                                                        Duration: 10.5 (±7.0) years                                                 Mood‐incongruent psychotic symptoms\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    RC\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Family history of psychiatric illness\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                    Number of episodes prior to lithium treatment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Kessing et al. [23](#acps13062-bib-0023){ref-type="ref"}         2011       3762      Level: na\                                                                  Sex\                                                                                                                Time to treatment failure                                                          Increased rates of non‐response associated with being female (*P* = 0.002), being unemployed/retired compared to employed (*P* \< 0.0001), depressive index episode (*P* \< 0.0001), increased number of hospitalisations (*P* = 0.0002), prelithium illness duration (*P* = 0.02), drug use (*P* = 0.05)                                                      
                                                                                        Duration: 0.5--10 years                                                     Age at lithium start\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Employment status\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                    Polarity of index episode\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                    Number of hospitalisations prior to lithium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Prelithium illness duration\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Drug use                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Degenhardt et al. [49](#acps13062-bib-0049){ref-type="ref"}      2012       230       Level: 0.6--1.2 mmol/l\                                                     Sex\                                                                                                                Time to treatment failure                                                          Onset age and body mass index uniquely predicted relapse in lithium vs. olanzapine‐ or valproate‐treated individuals. RC predicted relapse in lithium‐ and olanzapine‐treated individuals. Other covariates did not predict relapse                                                                                                                            
                                                                                        Duration: 52--72 weeks                                                      Polarity of index episode\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                    11 item Young Mania Rating Scale item scores\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    21 item Hamilton Depression Rating Scale total score\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Age at illness onset\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Body mass index\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                    Number of episodes prior to lithium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    RC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Guloksuz et al. [90](#acps13062-bib-0090){ref-type="ref"}        2012       60        Level: 0.80 (±0.12) mmol/l\                                                 Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Alda treatment response scale                                                      Lithium responders had lower body mass index (SMD −0.65, 95% CI −1.23 to −0.08). No difference by sex, age at onset, age at study start or number of hospitalisations                                                                                                                                                                                          
                                                                                        Duration: na                                                                Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Total episodes per year\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                    Number of hospitalisations prior to lithium[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Body mass index[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Martinsson et al. [91](#acps13062-bib-0091){ref-type="ref"}      2013       130       Level: 0.5--0.9 mmol/l\                                                     Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Alda treatment response scale                                                      RC and BPD II less common in lithium responders (*P* \< 0.05). No difference by sex or age                                                                                                                                                                                                                                                                     
                                                                                        Duration: na                                                                RC[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Type of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Age at study start                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Rybakowski et al. [92](#acps13062-bib-0092){ref-type="ref"}      2013       71        Level: 0.5--0.8 mmol/l\                                                     Personality traits: hyperthymic; anxiety; cyclothymic; depressive; irritable                                        Alda treatment response scale                                                      The response to lithium based on Alda scale correlated positively with hyperthymic temperament score (*r* = 0.31, *P* = 0.009), and negatively with anxiety (*r* = 0.27, *P* = 0.022), cyclothymic (*r* = 0.26, *P* = 0.032), and depressive (*r* = 0.23, *P* = 0.052) temperaments scores\                                                                   FAIR
                                                                                        Duration: 15 (±8) years                                                                                                                                                                                                                                                            No correlation found between lithium response and irritable temperament (*r* = 0.020, *P*‐value NS)                                                                                                                                                                                                                                                           

  Tharoor et al. [93](#acps13062-bib-0093){ref-type="ref"}         2013       122       Level: ≥0.6 mmol/l\                                                         Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Recurrence under lithium                                                           No difference in response by potential predictors                                                                                                                                                                                                                                                                                                              
                                                                                        Duration ≥2 years                                                           Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Number of episodes prior to lithium treatment[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                    Psychotic symptoms[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Family history of BPD[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Kessing et al. [24](#acps13062-bib-0024){ref-type="ref"}         2014       4714      Level: na\                                                                  Early (first contact) vs late initiation of lithium                                                                 Time to treatment failure                                                          Early starters of lithium had reduced non‐response rates (*P* \< 0.0001)                                                                                                                                                                                                                                                                                       
                                                                                        Duration:0.5--16 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Calkin et al. [47](#acps13062-bib-0047){ref-type="ref"}          2015       80        Level: na\                                                                  Glucose metabolism                                                                                                  Alda treatment response scale                                                      Insulin resistance or type 2 diabetes mellitus associated with poorer lithium response (*P* \< 0.0001)                                                                                                                                                                                                                                                         
                                                                                        Duration: ≥6 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Wei Shan et al. [43](#acps13062-bib-0043){ref-type="ref"}        2016       47        Level: 0.52--0.77 mmol/l\                                                   Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Proportion of time ill during lithium treatment                                    Predominance of depression over mania was associated with a good lithium response (*P* = 0.071)\                                                                                                                                                                                                                                                              FAIR
                                                                                        Duration: 3 years                                                           Ethnicity\                                                                                                                                                                                             Sex; ethnicity; family history; type of BPD; psychotic Symptoms; RC; mixed episodes; predominance of mania over depression; and polarity of first mood episode were not predictors of lithium response (p‐value NS).                                                                                                                                          
                                                                                                                                                                    Family history of any affective disorder[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                    Family history of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Type of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Psychotic symptoms[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    RC[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Mixed episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Predominant mood polarity[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Polarity of index episode[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Silva et al. [29](#acps13062-bib-0029){ref-type="ref"}           2016       40        Level: na\                                                                  Sex\                                                                                                                Alda treatment response scale                                                      High number of mood episodes with psychotic symptoms was associated with poor lithium response (*P* = 0.006),\                                                                                                                                                                                                                                                FAIR
                                                                                        Duration: ≥6 months                                                         Years of scholarship\                                                                                                                                                                                  History or current tobacco use was associated with poor lithium response (*P* = 0.0048).\                                                                                                                                                                                                                                                                     
                                                                                                                                                                    Age at onset\                                                                                                                                                                                          Sex; years of scholarship; age at onset; duration of the disorder; number of manic episodes; age at first manic episodes; number of depressive episodes; history of suicide attempt; presence of psychotic symptoms; family history of psychosis were not related to lithium response.                                                                        
                                                                                                                                                                    Duration of the disorder\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                    Number of manic episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                    Age at first manic episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Number of depressive episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    History of suicide attempt\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                    Psychotic symptoms\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Number of mood episodes with psychotic symptoms\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                    History of tobacco use\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                    Family history of psychosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Etain et al. [50](#acps13062-bib-0050){ref-type="ref"}           2017       148       Level: na\                                                                  Type of BPD\                                                                                                        Alda treatment response scale                                                      In multivariable analysis, poor response was associated with mixed episodes (*P* = 0.013) and physical abuse (0.005)\                                                                                                                                                                                                                                          
                                                                                        Duration: na                                                                Polarity of index episode\                                                                                                                                                                             In univariable analysis, poor response was additionally associated with alcohol use (*P* = 0.032) all other variables were NS.                                                                                                                                                                                                                                
                                                                                                                                                                    RC\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Mixed episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Suicide attempt\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                    Alcohol use\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Cannabis use\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                    Panic disorder\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Social phobia\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    GAD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    Physical abuse (childhood trauma questionnaire)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Saito et al. [94](#acps13062-bib-0094){ref-type="ref"}           2017       96        Level: na\                                                                  Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Alda treatment response scale                                                      Responders had fewer episodes prior to lithium (*P* = 0.012). sex (*P* = 0.379), age at study start (*P* = 0.993), education (*P* = 0.876), age at onset (*P* = 0.837), family history of BPD (*P* = 0.708) and psychotic features (*P* = 0.698) were not associated with response                                                                             
                                                                                        Duration: na                                                                Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Family history of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Psychotic symptoms[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Number of episodes prior to lithium treatment[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                    Years of education                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Scott et al. [53](#acps13062-bib-0053){ref-type="ref"}           2017       300       Level: na\                                                                  Sex\                                                                                                                Alda treatment response scale                                                      In multivariable model, full response best predicted by age at illness onset (*P* = 0.015), prelithium illness duration (*P* = 0.028), family history of BPD I (*P* = 0.026) and alcohol and drug use (*P* = 0.033)                                                                                                                                            
                                                                                        Duration: na                                                                Type of BPD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Polarity of index episode\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                    Family history of BPD I\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                    Age at illness onset\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Duration of illness\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                    Prelithium illness duration\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    RC\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Mixed episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    Alcohol and drug use\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Anxiety disorder\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                    Psychotic symptoms\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Number of mood stabilisers prior to lithium                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Sportiche et al. [46](#acps13062-bib-0046){ref-type="ref"}       2017       300       Level: na\                                                                  Sex[\*](#acps13062-note-2000){ref-type="fn"}\                                                                       Alda treatment response scale                                                      Mixed episode (*P* = 0.017) and alcohol use disorder (*P* = 0.015) were associated with poor lithium response\                                                                                                                                                                                                                                                FAIR
                                                                                        Duration: 36 months                                                         Age at study start[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                           Sex; current age; age at onset; duration of illness before lithium; BPD I; manic polarity at onset; seasonal pattern; psychotic symptoms; RC; attempted suicide; anxiety disorders; substance use disorders; family history BPD I and II were not lithium response predictors (*P*‐value NS)                                                                  
                                                                                                                                                                    Age at illness onset[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Prelithium illness duration[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Type of BPD[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                    Polarity of index episode[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                    Seasonal pattern\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                    Psychotic symptoms[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Mixed episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                    RC[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                    Attempted suicide\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                    Anxiety disorder\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                    Alcohol and drug use[\*](#acps13062-note-2000){ref-type="fn"}\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                    Family history of BPD[\*](#acps13062-note-2000){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BPD, bipolar disorder; CC, continuous cycling; CI, confidence interval; DMI, depression‐mania‐interval sequence; HR, hazard ratio; IRR, irregular sequence; MDI, mania‐depression‐interval sequence; na, not available; NS, non‐significant (at *P* = 0.05); PTSD, posttraumatic stress disorder; RC, rapid cycling; RR, risk ratio.

Data included in meta‐analysis.

John Wiley & Sons, Ltd

In total, 19 clinical variables were identified from the articles and further assessed as predictors of lithium response in at least two or more studies: (i) age at study start, (ii) age at illness onset, (iii) prelithium illness duration, (iv) number of episodes prior lithium treatment, (v) number of hospitalisations prior to lithium, (vi) type of BPD (BPD I vs. BPD II), (vii) interval course sequence (MDI vs. DMI), (viii) CC, (ix) irregular sequence (IRR) (absence of any regular mania‐depression‐sequence), (x) RC, (xi) index episode (mania vs. depression), (xii) predominant polarity (mania vs depression), (xiii) family history of any affective disorder, (xiv) family history of BPD, (xv) family history of lithium response, (xvi) alcohol and drug use, (xvii) psychotic symptoms, (xviii) sex and (xix) body mass index (BMI).

Age at illness onset {#acps13062-sec-0020}
--------------------

A total of 21 studies explored the effect of age at illness onset; five studies [25](#acps13062-bib-0025){ref-type="ref"}, [26](#acps13062-bib-0026){ref-type="ref"}, [27](#acps13062-bib-0027){ref-type="ref"}, [28](#acps13062-bib-0028){ref-type="ref"}, [29](#acps13062-bib-0029){ref-type="ref"} were excluded because of insufficient reporting; two studies reported categorical age data rather than continuous data and were therefore not included in meta‐analysis. The study by Okuma and colleagues [30](#acps13062-bib-0030){ref-type="ref"} categorised patients into four age groups (\>20; 21--30; 31--40; \<40) and found no association between age at illness onset and lithium response. However, a similar study conducted by Schurhoff et al. [31](#acps13062-bib-0031){ref-type="ref"} found that late onset (40 years old or older) was associated with good lithium response (*P* = 0.04). Pooling the remaining 14 eligible studies, with a total sample of 2063 patients, there was an association between age at onset and treatment response (SMD = 0.17; 95% CI: 0.02 to 0.33; *P* = 0.029; Fig. [2](#acps13062-fig-0002){ref-type="fig"}, Figure [S1](#acps13062-sup-0001){ref-type="supplementary-material"}), but heterogeneity was high (*I* ^2^ = 58.3.6%; *P* = 0.003). Of these included studies, four found increasing age was associated with increased chance of lithium response [32](#acps13062-bib-0032){ref-type="ref"}, [33](#acps13062-bib-0033){ref-type="ref"}, [34](#acps13062-bib-0034){ref-type="ref"}, [35](#acps13062-bib-0035){ref-type="ref"} and one found increased age was associated with a reduced chance of response [4](#acps13062-bib-0004){ref-type="ref"}.

![Relationship between clinical variables and lithium treatment response -- standardised mean difference of continuous variables. ^a^only two studies; ^b^ *I* ^2^ \> 50%.](ACPS-140-94-g002){#acps13062-fig-0002}

Age at study start {#acps13062-sec-0021}
------------------

The association between age at study start and lithium treatment response was quantified in 10 studies with a total sample of 1266 patients. A medium level heterogeneity was observed (*I* ^2^ = 50.8%; *P* = 0.032). The pooled effect estimate suggested no association between study admission age and lithium response (SMD: 0.02; 95% CI: −0.17 to 0.21; *P* = 0.851; Fig. [2](#acps13062-fig-0002){ref-type="fig"}, Figure [S1](#acps13062-sup-0001){ref-type="supplementary-material"}).

Prelithium illness duration {#acps13062-sec-0022}
---------------------------

Data from five studies with a sample of 931 patients were pooled (Table [1](#acps13062-tbl-0001){ref-type="table"}). Heterogeneity was low (*I* ^2^ = 0.0%; *P* = 0.701). The results suggested that a short prelithium treatment illness duration was associated with good lithium response (SMD = −0.26; 95% CI: −0.41 to −0.12; *P* \< 0.001; Fig. [2](#acps13062-fig-0002){ref-type="fig"}, Figure [S2](#acps13062-sup-0001){ref-type="supplementary-material"}). This was also true in the study by Kessing and colleagues of 4714 individuals with BPD [24](#acps13062-bib-0024){ref-type="ref"}; those commenced on lithium at first contact had lower rates of non‐response compared to those commenced at later contacts (HR 0.87, 95% CI 0.76 to 0.91, *P* \< 0.0001).

Number of episodes prior lithium treatment {#acps13062-sec-0023}
------------------------------------------

The impact of mean number of episodes prior to lithium treatment on treatment response was assessed in seven studies with a total sample of 824 (Table [1](#acps13062-tbl-0001){ref-type="table"}). Meta‐analysis suggested that increased number of mood episodes prior to commencing lithium was weakly associated with reduced chance of good response (SMD = −0.42; 95% CI: −0.84 to −0.01; *P* = 0.046; Fig. [2](#acps13062-fig-0002){ref-type="fig"}, Figure [S3](#acps13062-sup-0001){ref-type="supplementary-material"}). Heterogeneity was high (*I* ^2^ = 85.9%; *P* \< 0.001).

Number of hospitalisations prior to lithium treatment {#acps13062-sec-0024}
-----------------------------------------------------

A combined sample of 673 patients from four studies contributed data on number of previous hospitalisations. Although two studies suggested fewer hospitalisations were associated with good response [36](#acps13062-bib-0036){ref-type="ref"}, [37](#acps13062-bib-0037){ref-type="ref"}, overall there was no evidence of a clear association between number of hospitalisations and lithium response SMD = −0.40; 95% CI: −0.81 to 0.01; *P* = 0.055; Fig. [2](#acps13062-fig-0002){ref-type="fig"}, Figure [S3](#acps13062-sup-0001){ref-type="supplementary-material"}). In the Danish population [23](#acps13062-bib-0023){ref-type="ref"}, increasing number of hospitalisations between diagnosis and starting lithium were associated with increased rates on non‐response (HR 1.03, 95% CI 1.02 to 1.05, *P* = 0.0002).

Type of bipolar disorder {#acps13062-sec-0025}
------------------------

The association between BPD subtype and good lithium response was quantified in 11 studies with a total of 1556 patients. There was evidence of considerable heterogeneity (*I* ^2^ = 70.7%; *P* \< 0.001) across studies, and the result indicated insufficient evidence to support BPD I as a clinical predictor of lithium response when comparing to patients with BPD II (OR: 1.01; 95% CI: 0.58 to 1.76; *P* = 0.971; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S4](#acps13062-sup-0001){ref-type="supplementary-material"}).

![Relationship between clinical variables and lithium treatment response -- odds ratios of binary variables. ^b^ *I* ^2^ \> 50%.](ACPS-140-94-g003){#acps13062-fig-0003}

At an individual level, two of the included studies suggested BPD I may be associated with a preferential lithium response [32](#acps13062-bib-0032){ref-type="ref"}, [34](#acps13062-bib-0034){ref-type="ref"} and three suggested BPD II may be associated with a preferential lithium response [4](#acps13062-bib-0004){ref-type="ref"}, [33](#acps13062-bib-0033){ref-type="ref"}, [38](#acps13062-bib-0038){ref-type="ref"}.

Episode sequence {#acps13062-sec-0026}
----------------

A total of six studies, including 340 patients, compared MDI and DMI sequence. MDI patients were more likely to be lithium responders than DMI patients (OR 4.27; 95% CI 2.61 to 6.97; *P* \< 0.001; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S5](#acps13062-sup-0001){ref-type="supplementary-material"}). Heterogeneity was low (*I* ^2^ = 0.0%; *P* = 0.680).

Continuous cycling {#acps13062-sec-0027}
------------------

The impact of continuous cycling on lithium treatment response was quantified in seven studies with a total of 804 patients. Meta‐analysis suggested no association between continuous cycling and response (OR: 0.65; 95% CI: 0.34 to 1.26; *P* = 0.204; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S6](#acps13062-sup-0001){ref-type="supplementary-material"}).

Irregular sequence {#acps13062-sec-0028}
------------------

When the data from four studies of irregular sequence were pooled together, heterogeneity was low (*I* ^2^ = 0.0%; *P* = 0.496), and there was no association with lithium response (OR: 1.13; 95% CI: 0.70 to 1.83; *P* = 0.628, Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S6](#acps13062-sup-0001){ref-type="supplementary-material"}).

Rapid cycling {#acps13062-sec-0029}
-------------

The impact of the presence of RC on lithium treatment response was quantified in nine studies with a total of 1442 patients. Moderate heterogeneity was identified (*I* ^2^ = 37.5.6%; *P* = 0.119). The meta‐analysis result indicated evidence that patients displaying RC have reduced odds of lithium response compared to those without RC (OR: 0.30; 95% CI: 0.17 to 0.53; *P* \< 0.001; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S6](#acps13062-sup-0001){ref-type="supplementary-material"}).

Polarity of index episode {#acps13062-sec-0030}
-------------------------

There was no evidence of an association between lithium response and manic index episode (OR: 1.12; 95% CI: 0.56 to 2.21; *P* = 0.753; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S7](#acps13062-sup-0001){ref-type="supplementary-material"}). From six studies, one suggested a manic index episode was a good predictor of response [32](#acps13062-bib-0032){ref-type="ref"} and one suggested a depressive index episode was a good predictor [33](#acps13062-bib-0033){ref-type="ref"}. Others were inconclusive, and heterogeneity was high (*I* ^2^ = 73.7%; *P* = 0.002). Kessing et al. found reduced rates of non‐response in individuals with a manic index episode (HR 0.84, 95% CI 0.77 to 0.91) and elevated rates in those with a depressive index episode (HR 1.13, 95% CI 1.03 to 1.25) compared to those whose index episode was 'remission, other or unspecified'. However, it is unclear who is included in this reference category and there is potential misclassification because of the routine register‐based nature of the data source.

Predominant mood polarity {#acps13062-sec-0031}
-------------------------

Predominant mania or depression was documented in three studies with a total sample of 280 patients. Overall, there was no evidence for an association between lithium response and mania over depression dominance (OR: 1.07; 95% CI: 0.07 to 15.74; *P* = 0.959; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S8](#acps13062-sup-0001){ref-type="supplementary-material"}).

Included studies were contradictory; one study found a strong association between predominant mania and lithium non‐response (OR: 0.10; 95% CI: 0.04 to 0.25) [33](#acps13062-bib-0033){ref-type="ref"}, another found a strong association between predominant mania and lithium response (OR: 4.79; 95% CI 1.54 to 14.91) [30](#acps13062-bib-0030){ref-type="ref"}.

Family history {#acps13062-sec-0032}
--------------

Eight studies, including 714 individuals, contributed to meta‐analysis of the association between family history of any affective disorder and lithium response. There was no evidence of an association (OR: 1.13; 95% CI: 0.75 to 1.69; *P* = 0.560; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S9](#acps13062-sup-0001){ref-type="supplementary-material"}). Individuals with a family history of bipolar disorder were more likely to have a good response to lithium (10 studies, 1454 patients**;** OR: 1.61; 95% CI: 1.03 to 2.52; *P* = 0.036; *I* ^2^ = 43.5%; heterogeneity *P* = 0.068; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S9](#acps13062-sup-0001){ref-type="supplementary-material"}). One study, which could not be combined in meta‐analysis, runs contrary to this, finding 88% of individuals without a family history have a reduction in episode frequency during lithium treatment, while only 68% of those with a family history of BPD. Only two studies (79 patients) could be included in meta‐analysis of family history of lithium response. Both studies had point estimates suggesting good lithium response in family members may be associated with good response in the index patient, however, confidence intervals overlapped no effect (OR: 10.28; 95% CI: 0.66 to 161.26; *P* = 0.097, Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S9](#acps13062-sup-0001){ref-type="supplementary-material"}).

Alcohol and drug use {#acps13062-sec-0033}
--------------------

The association between alcohol and drug use and lithium response was investigated in three studies with a total sample of 540 patients. The results showed a medium heterogeneity (*I* ^2^ = 54.5%; *P* = 0.111) and demonstrated no evidence to suggest alcohol and drug use as a potential predictor of lithium response (OR: 0.55; 95% CI: 0.23 to 1.34; *P* = 0.189; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S10](#acps13062-sup-0001){ref-type="supplementary-material"}).

Psychotic symptoms {#acps13062-sec-0034}
------------------

A total sample of 1066 patients from eight studies were included in assessing psychotic symptoms. Medium heterogeneity was observed (*I* ^2^ = 42.8%; *P* = 0.093), and the result suggested a strong association between psychotic symptoms and poor response (OR: 0.52; 95% CI: 0.34 to 0.79; *P* = 0.002; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S11](#acps13062-sup-0001){ref-type="supplementary-material"}).

Sex {#acps13062-sec-0035}
---

The role of sex as a potential lithium response predictor was investigated 1,729 patients from 17 studies. Sex was not associated with lithium treatment response (being male OR: 0.89; 95% CI: 0.68 to 1.15; *P* = 0.356; *I* ^2^ = 22.7%; heterogeneity *P* = 0.191; Fig. [3](#acps13062-fig-0003){ref-type="fig"}, Figure [S12](#acps13062-sup-0001){ref-type="supplementary-material"}). However, the only population‐based study identified suggested an association between being female and non‐response (HR 1.12, 95% CI 1.04 to 1.21, *P* = 0.002) [23](#acps13062-bib-0023){ref-type="ref"}.

Body mass index {#acps13062-sec-0036}
---------------

BMI was investigated as a predictor in only two studies including 336 patients. In both studies, lower BMI was associated with better lithium response (pooled SMD: −0.61; 95% CI: −0.90 to −0.32; *P* \< 0.001; *I* ^2^ = 0.0%; heterogeneity *P* = 0.111 Fig. [2](#acps13062-fig-0002){ref-type="fig"}, Figure [S13](#acps13062-sup-0001){ref-type="supplementary-material"}).

Further potential predictors {#acps13062-sec-0037}
----------------------------

A study by Rybakowski et al. investigated the relationship between temperament and lithium response [39](#acps13062-bib-0039){ref-type="ref"}. Data from 71 patients suggested that lithium response was correlated positively with hyperthymic score (*r* = 0.31; *P* = 0.009), and negatively with anxiety and cyclothymic temperament scores (*r* = −0.27; *P* = 0.022 and *r *= −0.26; *P* = 0.032 respectively). We identified one other study which examined personality traits and treatment response [40](#acps13062-bib-0040){ref-type="ref"}. This study reported that responders had higher dominance scores (*P*‐value \< 0.05), lower neuroticism scores (*P*‐value \< 0.01) and were less likely to have 'deviant personalities' (*P*‐value \< 0.05). Social support was examined in two studies with overlapping study populations [36](#acps13062-bib-0036){ref-type="ref"}, [41](#acps13062-bib-0041){ref-type="ref"} and a third study which presented results in a way that did not permit meta‐analysis. Lower social support was associated with poor response in each case. Other sociodemographic characteristics were reported in a small number of studies. Social class was associated with response in one identified study, but not in another [36](#acps13062-bib-0036){ref-type="ref"}, [42](#acps13062-bib-0042){ref-type="ref"}. Education, marital status, [38](#acps13062-bib-0038){ref-type="ref"} and ethnicity [43](#acps13062-bib-0043){ref-type="ref"} were not associated with lithium response. Employment status was associated with response in one large nationwide population study [23](#acps13062-bib-0023){ref-type="ref"}, but not in a smaller observational study [38](#acps13062-bib-0038){ref-type="ref"}. Insulin resistance was found to be associated with poor response to lithium in one study, in keeping with the studies showing an association with BMI [47](#acps13062-bib-0047){ref-type="ref"}, [48](#acps13062-bib-0048){ref-type="ref"}, [49](#acps13062-bib-0049){ref-type="ref"}. While we did not consider childhood trauma as a 'clinical' predictor of treatment response, one included study examined this among other features [50](#acps13062-bib-0050){ref-type="ref"}. This study suggested physical abuse was an independent predictor of poor lithium response after accounting for many clinical characteristics. However, the only other study we could identify examining childhood trauma found no association between lithium response and any type of trauma [51](#acps13062-bib-0051){ref-type="ref"}.

Risk of bias within studies {#acps13062-sec-0038}
---------------------------

Overall, the mean Downs and Black quality assessment score was 16.3, which is considered fair quality. We identified eight good quality studies, 45 fair quality studies and 18 poor quality studies (Tables [S1](#acps13062-sup-0001){ref-type="supplementary-material"} and [S2](#acps13062-sup-0001){ref-type="supplementary-material"}). Most of the studies failed to report or account for appropriate confounders in regression analyses.

Risk of bias across studies {#acps13062-sec-0039}
---------------------------

In line with the Sterne et al. [52](#acps13062-bib-0052){ref-type="ref"}, funnel plot asymmetry was assessed when 10 or more studies were included in the meta‐analysis. Funnel plots were produced for age at illness onset (Figure [S14](#acps13062-sup-0001){ref-type="supplementary-material"}), sex (Figure [S15](#acps13062-sup-0001){ref-type="supplementary-material"}), family history of BPD (Figure [S16](#acps13062-sup-0001){ref-type="supplementary-material"}), age at study start (Figure [S17](#acps13062-sup-0001){ref-type="supplementary-material"}) and type of BPD (Figure [S18](#acps13062-sup-0001){ref-type="supplementary-material"}). The studies of BPD subtype, sex and family history produced asymmetrical funnel plots. A possible source of this asymmetry is true heterogeneity between studies; potentially because of differences in lithium dosage, treatment duration or diagnostic definition, small sample sizes and the low number of studies included.

Discussion {#acps13062-sec-0040}
==========

We identified a total of 71 studies, including over 12 000 patients which explore clinical predictors of lithium treatment response in patients with BPD. From these, six predictors of good response were identified. Our results suggest that predictors of good response are (i) MDI sequence, (ii) absence of RC, (iii) absence of psychotic symptoms, (iv) shorter prelithium illness duration, (v) family history of bipolar disorder and (vi) later illness onset. Additional features which may be related to response are body mass index, number of episodes before lithium treatment, number of hospitalisations before lithium and family history of lithium response.

Our findings generally correspond with previous review articles [8](#acps13062-bib-0008){ref-type="ref"}, [9](#acps13062-bib-0009){ref-type="ref"}, [10](#acps13062-bib-0010){ref-type="ref"}, [11](#acps13062-bib-0011){ref-type="ref"}. As far as we are aware, Kleindienst et al. conducted the only previous meta‐analysis of multiple clinical response predictors and our results were broadly similar [8](#acps13062-bib-0008){ref-type="ref"}. However, we did not find a strong association with number of previous hospitalisations or CC, and they found no association with prelithium illness duration, psychotic symptoms or RC. This may be because of differing approaches to study inclusion and analysis, and in some cases because contradictory results have been found in individual studies published since 2005. Additionally, prelithium illness duration, number of episodes prior to lithium treatment and number of hosptialisations prior to lithium are likely to all be measuring a similar underlying concept.

Clinically, these predictors are likely to be of varying importance. Some may essentially reflect establishing a more benign illness course because of early intervention and may not be specific to lithium. This may be the case for shorter prelithium illness duration, and fewer episodes prior to lithium treatment, which are clearly related to illness severity. Others may be more central to guiding the choice to use lithium. DMI sequence, rapid cycling and psychotic symptoms are all associated with poor lithium response, so their presence may suggest an alternative treatment might be more appropriate for the patient. However, there is limited evidence to suggest any other drug therapy would lead to better than responses than with lithium. Family history of bipolar disorder and potentially family history of lithium response (likely under powered in our analysis) are important as they may reflect a more heritable subtype of BPD.

Limitations {#acps13062-sec-0041}
-----------

The reliability of the potential predictors identified remains unclear. For most of the meta‐analyses conducted, estimates were highly heterogeneous, often including studies suggesting both a positive and negative effect of the predictor. Most studies were rated as fair or poor in terms of quality. Often insufficient statistical information was reported in the primary study to conduct meta‐analysis; most studies failed to report adequate summary statistics such as standard deviation or number of responders and non‐responders. Sample sizes were often small and studies consisted of highly selective groups of patients. Also, the definition of lithium response in many of the studies did not rely on a standardised tool, which can greatly influence the process of identifying lithium responders and lithium non‐responders. As shown in Table [1](#acps13062-tbl-0001){ref-type="table"}, most of the studies relied on recurrence of an affective episode under lithium treatment to define lithium non‐responders. However, this definition of lithium response fails to consider changes in episode frequency or symptom severity, and so may miscategorise responders and non‐responders. Scott and colleagues note that using continuous scores for lithium response as opposed to categories of response leads to different predictors being identified [53](#acps13062-bib-0053){ref-type="ref"}. Additionally, none of the studies reported lithium plasma level or adherence to treatment by response status. Information on these factors would strengthen the argument that these are true predictors of lithium response as it would then be possible to rule out differences in the way treatment is used as a cause of the observed associations.

Very few of the studies explored the possibility of interdependence or interaction between predictors. For example, interdependence might exist between prelithium illness duration and illness severity [54](#acps13062-bib-0054){ref-type="ref"}. A greater illness severity is related to receiving early treatment and subsequently decreasing illness morbidity. Accordingly, a short prelithium illness duration might appear to be related to good lithium response [54](#acps13062-bib-0054){ref-type="ref"}. Only some of the more recent studies included multiple covariates in the same model (for example; [23](#acps13062-bib-0023){ref-type="ref"}, [50](#acps13062-bib-0050){ref-type="ref"}, [53](#acps13062-bib-0053){ref-type="ref"}) an approach which is necessary to determine whether covariates are truly *independent* predictors.

Because of the low reliability of the results and the inability to eliminate biases, any clinical conclusions relating to any single predictor should be made cautiously. Because of the limitations of the data, particularly the limited number of RCTs, it is difficult to separate predictors of lithium response from predictors of a benign illness course.

In conclude although we identified six potential clinical predictors of lithium response, there are a number of issues relating to their reliability and validity which cannot be addressed by reviewing the existing literature. As with response classification by genetic or biological markers, clinical response prediction is likely to be complex and multivariable. Studies need to explore multiple predictors, and their interactions, with operationalised end points for lithium response.
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